Cargando…

A Bombesin-Shepherdin Radioconjugate Designed for Combined Extra- and Intracellular Targeting

Radiolabeled peptides which target tumor-specific membrane structures of cancer cells represent a promising class of targeted radiopharmaceuticals for the diagnosis and therapy of cancer. A potential drawback of a number of reported radiopeptides is the rapid washout of a substantial fraction of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fischer, Christiane A., Vomstein, Sandra, Mindt, Thomas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078514/ https://www.ncbi.nlm.nih.gov/pubmed/24871806 http://dx.doi.org/10.3390/ph7060662

Ejemplares similares

Therapeutic targeting of tumor hypoxia and necrosis with antibody α-radioconjugates
por: Staudacher, Alexander H, et al.
Publicado: (2018)

Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer
por: Lankoff, Anna, et al.
Publicado: (2023)

In Vitro Biological Evaluation of Aprepitant Based (177)Lu-Radioconjugates
por: Halik, Paweł K., et al.
Publicado: (2022)

Targeting prostate cancer with radiolabelled bombesins
por: Maina, Theodosia, et al.
Publicado: (2006)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
por: Guzik, Patrycja, et al.
Publicado: (2020)

Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin
por: Reissig, Falco, et al.
Publicado: (2022)

Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
por: Zhang, Hanwen, et al.
Publicado: (2012)

Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy
por: Dawicki, Wojciech, et al.
Publicado: (2020)

Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates
por: Busslinger, Sarah D., et al.
Publicado: (2023)

Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
por: Woll, P. J., et al.
Publicado: (1988)

Role of the neuropeptide, bombesin, in bile secretion.
por: Cho, W. K.
Publicado: (1997)

Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells
por: Akbar, Mohammad J, et al.
Publicado: (2019)

Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
por: Huynh, Truc T., et al.
Publicado: (2022)

Molecular recognition of itch-associated neuropeptides by bombesin receptors
por: Li, Changyao, et al.
Publicado: (2022)

Bombesins: A New Frontier in Hybrid Compound Development
por: Serafin, Pawel, et al.
Publicado: (2023)

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
por: Schroeder, Rogier P. J., et al.
Publicado: (2010)

Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors
por: Halik, Paweł K., et al.
Publicado: (2020)

Novel NK1R-Targeted (68)Ga-/(177)Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships
por: Matalińska, Joanna, et al.
Publicado: (2022)

Bombesin stimulates proliferation of human breast cancer cells in culture.
por: Nelson, J., et al.
Publicado: (1991)

Stress and eating: a dual role for bombesin-like peptides
por: Merali, Z., et al.
Publicado: (2013)

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)

Bombesine in critically ill patients receiving enteral and total parenteral nutrition
por: Moukas, M, et al.
Publicado: (2002)

AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists
por: Moody, Terry W., et al.
Publicado: (2017)

HYNIC and DOMA conjugated radiolabeled bombesin analogs as receptor-targeted probes for scintigraphic detection of breast tumor
por: De, Kakali, et al.
Publicado: (2019)

Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells
por: Wen, Xiaodong, et al.
Publicado: (2011)

Mechanism of bombesin-induced tonic contraction of the porcine lower esophageal sphincter
por: Tsai, Ching-Chung, et al.
Publicado: (2015)

Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent
por: Accardo, Antonella, et al.
Publicado: (2012)

Identification of ChIP-seq mapped targets of HP1β due to bombesin/GRP receptor activation
por: Tell, Robert, et al.
Publicado: (2011)

Evaluation of a new radiolabeled bombesin derivative with (99m)Tc as potential targeted tumor imaging agent
por: Sadeghzadeh, N., et al.
Publicado: (2013)

The Effect of Central Injection of Ghrelin and Bombesin on Mean Plasma Thyroid Hormones Concentration
por: Mahmoudi, Fariba, et al.
Publicado: (2011)

Triamterene Suppresses Bombesin‐enhanced Peritoneal Metastasis of Intestinal Adenocarcinomas Induced by Azoxymethane
por: Iishi, Hiroyasu, et al.
Publicado: (1996)

New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding
por: Rasaeifar, Bahareh, et al.
Publicado: (2020)

Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy
por: Moody, Terry W., et al.
Publicado: (2021)

Optimization of the Pharmacokinetic Profile of [(99m)Tc]Tc-N(4)-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence
por: Günther, Thomas, et al.
Publicado: (2022)

Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa
por: Chave, H S, et al.
Publicado: (2000)

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215
por: Szereday, Z, et al.
Publicado: (2002)

Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours
por: Chilug, Livia Elena, et al.
Publicado: (2020)

Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
por: Gomena, Jacopo, et al.
Publicado: (2023)

Search for an Endogenous Bombesin-Like Receptor 3 (BRS-3) Ligand Using Parabiotic Mice
por: Lateef, Dalya M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a6i42d4s5e5jbqml07orn1g1ub